ecancermedicalscience

Short Communication

Molecular characterisation of signalling pathways in cancer stem cells

2 Dec 2008
C Regenbrecht, Y Welte, A Jödicke, R Hugel, P Walden, M Jung, H Lehrach, J Adjaye

To avoid artefacts introduced by culturing cells for extended periods of time, it is crucial to use low-passage patient-derived tumour cells. The ability to enrich, isolate and assay sub-populations of cells that behave as cancer stem cells (CSCs) from these primary cell lines is essential before performing characterisations such as gene-expression profiling. We have isolated cells from glioblastomas which show characteristics of CSCs. Although glioblastomas contain only a relatively small amount of putative CSCs, these cells express many genes which seem to be worthy targets for future therapies.

Article metrics: 567 views
295
272

Related Articles

Luca Nicosia, Antuono Latronico, Mariagiorgia Farina, Anna Carla Bozzini, Paola Baratella, Viviana Enrica Galimberti, Stefano Fiori, Marta Montesano, Enrico Cassano
Maria Asunción Algarra, Maria José Juan Fita, Sergio Sandiego, Héctor Augusto Aguilar, Pablo Álvarez, Mateo Quispe, Antonio Salvador, Adoración Egido, Javier Lavernia, Isidro Machado, José Rubio Briones, Miguel Ángel Climent
Veronica Martini, Francesca D'Avanzo, Paola Maria Maggiora, Feba Maria Varughese, Antonio Sica, Alessandra Gennari
Elham Sajjadi, Konstantinos Venetis, Cristian Scatena, Nicola Fusco
Lekha Madhavan Nair, KM Jagathnath Krishna, Aswin Kumar, Susan Mathews, John Joseph, Francis Vadakkumparambil James